Cargando…

Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis

BACKGROUND: Transcription factor CP2 (TFCP2) is overexpressed in hepatocellular carcinoma(HCC) and correlated with the progression of the disease. Here we report the use of an integrated systems biology approach to identify genome-wide scale map of TFCP2 targets as well as the molecular function and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiao, Liu, Zhikun, Zhou, Lin, Xie, Haiyang, Cheng, Jun, Ling, Qi, Wang, Jianguo, Guo, Haijun, Wei, Xuyong, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311423/ https://www.ncbi.nlm.nih.gov/pubmed/25609232 http://dx.doi.org/10.1186/s13046-015-0121-1

Ejemplares similares

TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2017)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

miRNA profiles in livers with different mass deficits after partial hepatectomy and miR-106b~25 cluster accelerating hepatocyte proliferation in rats
por: Xu, Xiao, et al.
Publicado: (2016)

MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis
por: Wang, Wei, et al.
Publicado: (2022)

Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action
por: Taracha, Agnieszka, et al.
Publicado: (2018)

TJP1, a Membrane-Expressed Protein, is a Potential Therapeutic and Prognostic Target for Lung Cancer
por: Pu, Junyi, et al.
Publicado: (2022)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter
por: Shao, Keke, et al.
Publicado: (2021)

The Structural and Functional Organization of the Podocyte Filtration Slits Is Regulated by Tjp1/ZO-1
por: Itoh, Masahiko, et al.
Publicado: (2014)

CircSMC3 regulates gastric cancer tumorigenesis by targeting miR‐4720‐3p/TJP1 axis
por: Xia, Tianfang, et al.
Publicado: (2020)

Implications for Collagen Binding from the Crystallographic Structure of Fibronectin (6)FnI(1–2)FnII(7)FnI
por: Erat, Michèle C., et al.
Publicado: (2010)

Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma
por: Xu, Xiao, et al.
Publicado: (2016)

The tight junction protein TJP1 regulates the feeding-modulated hepatic circadian clock
por: Liu, Yi, et al.
Publicado: (2020)

Klf2 and Tfcp2l1, Two Wnt/β-Catenin Targets, Act Synergistically to Induce and Maintain Naive Pluripotency
por: Qiu, Dongbo, et al.
Publicado: (2015)

Requirement for STAT3 and its target, TFCP2L1, in self-renewal of naïve pluripotent stem cells in vivo and in vitro
por: Kraunsoe, Sophie, et al.
Publicado: (2023)

CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
por: Liu, Ya, et al.
Publicado: (2019)

Cellular Distribution Pattern of tjp1 (ZO-1) in Xenopus laevis Oocytes Heterologously Expressing Claudins
por: Brunner, Nora, et al.
Publicado: (2022)

Transcription factor LSF (TFCP2) inhibits melanoma growth
por: Goto, Yuji, et al.
Publicado: (2015)

The disconnect2 mutation disrupts the tjp1b gene that is required for electrical synapse formation
por: Michel, Jennifer Carlisle, et al.
Publicado: (2022)

Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis
por: Heo, Jinbeom, et al.
Publicado: (2019)

Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma
por: Wang, Lijun, et al.
Publicado: (2015)

Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
por: Liu, Ya, et al.
Publicado: (2022)

Transcription factor TFCP2L1 patterns cells in the mouse kidney collecting ducts
por: Werth, Max, et al.
Publicado: (2017)

circITCH suppresses cell proliferation and metastasis through miR‐660/TFCP2 pathway in melanoma
por: Zhang, Jianfei, et al.
Publicado: (2022)

The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
por: Zhou, Hong, et al.
Publicado: (2012)

Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
por: Gunadi, et al.
Publicado: (2019)

TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma
por: Lee, Eun-Young, et al.
Publicado: (2021)

TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
por: Yuedi, Dai, et al.
Publicado: (2017)

Temporal and spatial staging of lung alveolar regeneration is determined by the grainyhead transcription factor Tfcp2l1
por: Cardenas-Diaz, Fabian L., et al.
Publicado: (2023)

MicroRNA-219c-5p regulates bladder fibrosis by targeting FN1
por: Liu, Bowen, et al.
Publicado: (2020)

ZO-2/Tjp2 suppresses Yap and Wwtr1/Taz-mediated hepatocyte to cholangiocyte transdifferentiation in the mouse liver
por: Xu, Jianliang, et al.
Publicado: (2022)

Structure of unliganded membrane-proximal domains FN4-FN5-FN6 of DCC
por: Finci, Lorenzo I., et al.
Publicado: (2017)

A novel TJP1-ROS1 fusion in malignant peripheral nerve sheath tumor responding to crizotinib: A case report
por: Li, Juming, et al.
Publicado: (2020)

Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

TFCP2 is a transcriptional regulator of heparan sulfate assembly and melanoma cell growth
por: Basu, Amrita, et al.
Publicado: (2023)

TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
por: Yu, Jiongjie, et al.
Publicado: (2023)

Fn14•Trail Effectively Inhibits Hepatocellular Carcinoma Growth
por: Aronin, Alexandra, et al.
Publicado: (2013)

Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma
por: Du, Chengli, et al.
Publicado: (2015)

The transcription factor Tfcp2l1 promotes primordial germ cell–like cell specification of pluripotent stem cells
por: Zhang, Meng, et al.
Publicado: (2021)

Case report: EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas
por: Panferova, Agnesa V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d7em41e6qskp6c4sk68c1f06v6